Rheumatoid arthritis is an autoimmune disease normal in adult, particularly in ladies. The disease affects peripheral joints, incorporating the wrists, feet, ankles, and knees. The cause is obscure and eyes and skin can also be included. Early aggressive therapy with immunosuppressive medications and anti-inflammatories seems to postpone joint destruction. More recently, biologic agents have been added to regimens that include TNF inhibitors, WBC modulators, and growth factor inhibitors. Research is progressing to assess the impacts of stem cells on auto-immune conditions. According to the Journal of Translational Research, “The capability of MSC to inhibit immune response, while offering the plausibility of inducing/accelerating healing of tissue that has already been damaged, makes this population attractive for treatment of autoimmune disorders.” Read more…
Rheumatoid Arthritis and Regenerative Medicine Institute of Nevada
Regenerative Medicine Institute of Nevada has developed a particular SVF deployment protocol that attempts to utilize the potential immune-modulatory, anti-inflammatory, and regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is deployed systemically and may require repeat dosing. This is carried out as an outpatient around the time of SVF collecting and obtainment. The whole cell surgical system takes roughly three hours.
Rheumatoid Arthritis Call to Action
In caring for our Rheumatoid Arthritis patients at the Regenerative Medicine Institute of Nevada, we take pride in using the best medical protocols and current technology to help our patients become their best. Contact us and we will answer the inquiries and concerns you might have about Regenerative Medicine Institute of Nevada protocols for Rheumatoid Arthritis.